Skip to content

Drug interactions

Irinotecan + Meningococcal group b vaccine

Severity: Moderate

Irinotecan and Meningococcal group b vaccine: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Irinotecan causes myelosuppression and immunosuppression, which may blunt the antibody response to meningococcal B vaccination. The vaccine is inactivated and not unsafe, but protection may be inadequate.

What this interaction means in plain words

Irinotecan and Meningococcal group b vaccine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Evidence level: Moderate

Why it happens

Chemotherapy-induced immunosuppression reduces vaccine immune response.

What to do

Vaccinate at least two weeks before chemotherapy when possible, or consider revaccination or antibody checks after recovery of counts.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Irinotecan and Meningococcal group b vaccine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Irinotecan with Meningococcal group b vaccine?

MediHelp rates the interaction as moderate. Irinotecan and Meningococcal group b vaccine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Irinotecan causes myelosuppression and immunosuppression, which may blunt the antibody response to meningococcal B vaccination. The vaccine is inactivated and not unsafe, but protection may be inadequate.

How serious is the interaction between Irinotecan and Meningococcal group b vaccine?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Vaccinate at least two weeks before chemotherapy when possible, or consider revaccination or antibody checks after recovery of counts.

What other medicines interact with Irinotecan?

MediHelp also lists interactions of Irinotecan with, for example, Clozapine, Sacituzumab govitecan, Adenovirus types 4 and 7 live. The full list is on the Irinotecan page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in